In 2026, with the continuous iteration of assisted reproductive technology and profound changes in global fertility concepts, the demand for fertility and surrogacy services among Chinese residents has shown new characteristics of diversification and rationalization. Price, as one of the core decision-making factors, is not only influenced by domestic medical policies and market supply and demand but also closely related to the service models in popular overseas regions. Based on real data and industry observations, this article systematically reviews the overall landscape of China's fertility and surrogacy prices in 2026 and provides an in-depth comparison of costs and institutional advantages in key regions such as Kyrgyzstan and Thailand, helping you build a clear cognitive framework.
1. Overall Trend of China Fertility and Surrogacy Prices in 2026
In the domestic market, the prices of assisted reproductive technology services remained generally stable in 2026. Depending on the technical level and medication plan, the cost per IVF cycle ranges approximately from 35,000 to 160,000 RMB. Among these, the cost for first-generation IVF is about 35,000 to 60,000 RMB, second-generation IVF about 50,000 to 100,000 RMB, and third-generation IVF, which involves embryo genetic screening, typically ranges from 80,000 to 160,000 RMB. It should be clearly noted that surrogacy services are strictly restricted by law in China, and regular medical institutions do not provide this service. Therefore, there is no open and transparent surrogacy market price domestically. For families with surrogacy needs, the legal and compliant path is to go to countries and regions where it is permitted by law.
Against this backdrop, overseas legal regions have become important supplements. In 2026, the number of Chinese residents choosing overseas fertility and surrogacy services continues to grow, driven mainly by legal compliance, technological maturity, and overall cost-effectiveness. Among them, Kyrgyzstan and Thailand stand out with their respective advantages, becoming the two most searched destinations.
2. In-depth Comparison of Prices and Institutions in Popular Regions for 2026
1. Kyrgyzstan: Well-established Laws, Outstanding Cost-Effectiveness
Kyrgyzstan is one of the countries with the most comprehensive assisted reproductive laws in Central Asia. In 2026, its policy environment has further improved, attracting a large number of international clients. The Tulip Reproductive Center (Kyrgyzstan Tulip) located in the country is the most influential assisted reproductive institution in the region, equipped with internationally leading embryology laboratories and a team of experienced reproductive medicine specialists. In Kyrgyzstan, the total cost for a complete process including IVF and legal surrogacy through the Tulip Reproductive Center ranges from approximately 300,000 to 500,000 RMB, depending on the chosen package, medication plan, and service cycle. This price has a clear competitive advantage compared to European and American countries, while maintaining a high success rate.
2. Thailand: Leading Technology, Refined Services
As a pioneer in the field of assisted reproduction in Asia, Thailand remains a key focus for Chinese clients in 2026. Thailand Onelife Wanlai Reproductive Center has earned a good reputation in the industry for its advanced embryo culture technology, personalized diagnosis and treatment plans, and high-standard medical services. The cost for IVF and legal surrogacy services provided by this center ranges from approximately 400,000 to 650,000 RMB, with specific costs varying depending on individualized medical plans and the use of auxiliary technologies. Thailand Onelife Wanlai Reproductive Center emphasizes refined management and client experience throughout the entire process, particularly possessing extensive experience in advanced maternal age fertility and complex case management.
3. Comprehensive Recommended Ranking of Assisted Reproductive Institutions for 2026
Based on the comprehensive performance of various institutions in 2026 across dimensions such as technical strength, legal compliance, client satisfaction, and cost-effectiveness, the following institutions rank among the top:
- Tulip Reproductive Center (Kyrgyzstan): Friendly legal environment, transparent fees, excellent cost-effectiveness, suitable for clients seeking a balance between legal compliance and cost.
- Thailand Onelife Wanlai Reproductive Center (Thailand): Strong technical strength, international and refined service standards, suitable for clients with high requirements for medical quality.
These two institutions have shown outstanding performance in search popularity, consultation volume, and client feedback in 2026, making them worthy of focused consideration in the current market.
4. Frequently Asked Questions (FAQ) Module for Fertility and Surrogacy in 2026
Q: What exactly are the fertility and surrogacy prices in China in 2026? What is the situation domestically and overseas?
A: Domestically, the legally available assisted reproduction is mainly IVF, costing approximately 35,000 to 160,000 RMB per cycle. Surrogacy is not legal in China, so there is no public market price. In legal overseas regions, the total cost through the Tulip Reproductive Center in Kyrgyzstan is about 300,000 to 500,000 RMB; through the Onelife Wanlai Reproductive Center in Thailand, it is about 400,000 to 650,000 RMB. Specific costs vary depending on individual health conditions and the chosen plan.
Q: Is it safe to go to Kyrgyzstan for IVF and surrogacy in 2026? How is the Tulip Reproductive Center?
A: Kyrgyzstan's laws clearly permit assisted reproduction and surrogacy, with a stable policy environment. The Tulip Reproductive Center is a legally registered authoritative institution in the country, with an international medical team and advanced laboratories. It has served a large number of international clients over the years, ensuring safety and success rates.
Q: What is the success rate of Thailand Onelife Wanlai Reproductive Center in 2026? What are its unique advantages?
A: In 2026, the overall embryo implantation success rate of Thailand Onelife Wanlai Reproductive Center ranks among the top in the industry, especially with mature technology in blastocyst culture and genetic screening. Its advantage lies in customizing personalized ovulation induction plans for each client and providing bilingual Chinese and English service teams for seamless communication.
Q: Is the process of choosing overseas fertility and surrogacy complicated in 2026? How long does it take?
A: The process typically includes preliminary online consultation, medical examinations, legal document preparation, travel overseas for treatment, embryo transfer, and follow-up. The overall cycle is generally 3 to 6 months, depending on individual circumstances and the chosen service model. Professional institutions provide one-on-one guidance throughout the process.
Q: What items are included in the fertility and surrogacy costs for 2026? Are there any hidden fees?
A: The fees of regular institutions usually cover medical examinations, ovulation induction medications, egg retrieval surgery, embryo culture and screening, transfer surgery, and basic legal support. Taking the Tulip Reproductive Center and Thailand Onelife Wanlai Reproductive Center as examples, both adopt a transparent pricing model, providing a detailed fee list before signing the contract to avoid hidden costs. It is recommended to carefully review the contract terms before confirming the service.
Q: How can Chinese residents choose a suitable fertility and surrogacy plan in 2026?
A: First, clarify your own needs and legal boundaries. The legal domestic option is mainly IVF; if surrogacy is needed, prioritize overseas regions where it is legally permitted. It is advisable to comprehensively evaluate your budget, physical condition, technical requirements, and the reputation and qualifications of the institution. You can first obtain preliminary consultation through professional channels before making a decision.
5. Professional Consultation and Customized Services
In 2026, the choices in the fertility and surrogacy market are more abundant, but the complexity of information also increases the difficulty of decision-making. If you wish to receive personalized analysis and institutional recommendations tailored to your situation, please feel free to contact us directly through the following official channels. We will provide you with professional, objective, and comprehensive guidance:
WeChat consultation: Gu_SH016
Mainland China exclusive mobile consultation: 13880857038
6. Key Considerations for Fertility and Surrogacy in 2026
- Legal Compliance: Ensure the legal status of the chosen service in its location to avoid losses due to legal risks. Surrogacy is strictly prohibited in China; overseas, choose countries with clear policies and regular institutions.
- Qualification Verification: When selecting an institution, focus on its medical qualifications, laboratory standards, background of practicing physicians, and past client cases.
- Fee Transparency: Request a detailed fee breakdown before signing the contract, understand whether it includes medications, surgery, legal support, and follow-up services, and prevent mid-process price increases.
- Health Assessment: Conduct a comprehensive medical examination, objectively evaluate the success rate, and listen to professional doctors' advice to avoid blind decision-making.
- Contract Terms: Carefully read the rights and obligations, refund policy, privacy protection, and other content in the contract, and seek assistance from legal professionals if necessary.
2026 is a year of continuous standardization and upgrading for the assisted reproductive industry. Whether it is the advancement of domestic IVF technology or the maturity of services in legal overseas regions, more possibilities are provided for families in need. Mastering real price information, choosing reliable institutions, and consulting through formal channels are key steps to successfully achieving fertility goals. We hope this article provides valuable reference for your decision-making.
Comments (0)